Literature DB >> 28575513

Primary, Enduring Negative Symptoms: An Update on Research.

Brian Kirkpatrick1, Armida Mucci2, Silvana Galderisi3.   

Abstract

We previously proposed that people with schizophrenia who have primary, enduring negative symptoms have a disease-deficit schizophrenia (DS)-that is separate from that affecting people with schizophrenia without these features. Additional evidence consistent with the separate disease hypothesis has accumulated in recent years. White matter changes may be widespread in deficit compared to nondeficit patients and may relate to problems in early brain migration. These 2 patient groups also appear to differ on metabolic measures prior to antipsychotic treatment. Studies of reward and defeatist beliefs provide the basis for future treatment trials. The 2 factors or groups within negative symptoms broadly defined (both primary and secondary) have also been found in DS, and recent evidence suggests these 2 symptom groups have different correlates and reflect the existence of 2 groups with in DS. Negative symptoms are found in disorders other than schizophrenia, and excess summer birth, a deficit risk factor, has been found in a non-patient group with deficit-like features. It may be useful in future research to determine whether findings in DS extend to patients with other neuropsychiatric disorders who also have negative symptoms.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  deficit schizophrenia; negative symptoms; nosology; psychopathology; schizophrenia

Mesh:

Year:  2017        PMID: 28575513      PMCID: PMC5472155          DOI: 10.1093/schbul/sbx064

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  68 in total

Review 1.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  Left nucleus accumbens atrophy in deficit schizophrenia: A preliminary study.

Authors:  Pietro De Rossi; Claudia Dacquino; Fabrizio Piras; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Psychiatry Res Neuroimaging       Date:  2016-06-07       Impact factor: 2.376

5.  Multi-components of evoked-brain potentials in deficit and nondeficit schizophrenia.

Authors:  Zhe Li; Bo Zheng; Wei Deng; Xiang Liu; Zhong Zheng; Tao Li
Journal:  Asia Pac Psychiatry       Date:  2013-03-12       Impact factor: 2.538

6.  P50 gating in deficit and nondeficit schizophrenia.

Authors:  José Luis Santos; Eva María Sánchez-Morla; Ana Aparicio; María Angeles García-Jiménez; Clara Villanueva; Vicente Martínez-Vizcaíno; Celso Arango
Journal:  Schizophr Res       Date:  2010-02-12       Impact factor: 4.939

7.  Components of the smooth pursuit function in deficit and nondeficit schizophrenia.

Authors:  L Elliot Hong; Matthew T Avila; Helene Adami; Amie Elliot; Gunvant K Thaker
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

8.  Olfactory hedonic judgment in patients with deficit syndrome schizophrenia.

Authors:  Gregory P Strauss; Daniel N Allen; Sylvia A Ross; Lisa A Duke; Jason Schwartz
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

9.  Reduced anterior cingulate gray matter volume and thickness in subjects with deficit schizophrenia.

Authors:  Mizuho Takayanagi; Jacqueline Wentz; Yoichiro Takayanagi; David J Schretlen; Elvan Ceyhan; Lei Wang; Michio Suzuki; Akira Sawa; Patrick E Barta; J Tilak Ratnanather; Nicola G Cascella
Journal:  Schizophr Res       Date:  2013-09-12       Impact factor: 4.939

10.  White matter alterations in deficit schizophrenia.

Authors:  Laura M Rowland; Elena A Spieker; Alan Francis; Peter B Barker; William T Carpenter; Robert W Buchanan
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

View more
  22 in total

1.  An Early Developmental Marker of Deficit versus Nondeficit Schizophrenia.

Authors:  Brian Kirkpatrick; Özlem Gürbüz Oflezer; Mehtap Delice Arslan; Gary Hack; Emilio Fernandez-Egea
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

2.  Negative Symptom Therapeutics.

Authors:  William T Carpenter; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

3.  Digital phenotyping of negative symptoms: the relationship to clinician ratings.

Authors:  Alex S Cohen; Elana Schwartz; Thanh P Le; Tovah Cowan; Brian Kirkpatrick; Ian M Raugh; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

4.  Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.

Authors:  Wing Chung Chang; Ryan Wui Hang Ho; Jennifer Yee Man Tang; Corine Sau Man Wong; Christy Lai Ming Hui; Sherry K W Chan; Edwin M H Lee; Yi Nam Suen; Eric Y H Chen
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

5.  Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.

Authors:  Anthony O Ahmed; Brian Kirkpatrick; Eric Granholm; Laura M Rowland; Peter B Barker; James M Gold; Robert W Buchanan; Tacina Outram; Miguel Bernardo; María Paz García-Portilla; Anna Mane; Emilio Fernandez-Egea; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

6.  From Memories of Past Experiences to Present Motivation? A Meta-analysis on the Association Between Episodic Memory and Negative Symptoms in People With Psychosis.

Authors:  Matthias Pillny; Katarina Krkovic; Laura Buck; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

7.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

Review 8.  Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques.

Authors:  Ginetta Collo; Armida Mucci; Giulia M Giordano; Emilio Merlo Pich; Silvana Galderisi
Journal:  Front Neurosci       Date:  2020-06-18       Impact factor: 4.677

9.  Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.

Authors:  Giulia M Giordano; Thomas Koenig; Armida Mucci; Annarita Vignapiano; Antonella Amodio; Giorgio Di Lorenzo; Alberto Siracusano; Antonello Bellomo; Mario Altamura; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Neuroimage Clin       Date:  2018-08-31       Impact factor: 4.881

10.  Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.

Authors:  Xiaowei Tang; Chao Zhou; Ju Gao; Weiwei Duan; Miao Yu; Wenhuan Xiao; Xiaobin Zhang; Hui Dong; Xiang Wang; Xiangrong Zhang
Journal:  BMC Psychiatry       Date:  2019-08-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.